MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
May 18, 2020

FDA Grants Fast Track Designation for Heart Failure Developmental Treatment

By Adam Hochron
The FDA has granted fast track designation for omecamtiv mecarbil for the treatment of chronic heart failure with reduced ejection fraction...
FDA Grants Fast Track Designation for Heart Failure Developmental Treatment
May 18, 2020

Masitinib Reduced Exacerbation Rate in Patients with Severe Persistent Asthma

By Jeff Craven /alert Contributor
The selective tyrosine kinase inhibitor masitinib was effective as an add-on therapy in reducing exacerbations in patients with severe persistent asthma uncontrolled by oral corticosteroids...
Masitinib Reduced Exacerbation Rate in Patients with Severe Persistent Asthma
May 15, 2020

Patient Characteristics May Not Always Determine Effectiveness of Biologics for Asthma

By Jeff Craven /alert Contributor
Patient characteristics alone may not determine who is a good candidate for biologics for treatment of asthma, according to a recent case study...
Patient Characteristics May Not Always Determine Effectiveness of Biologics for Asthma
May 13, 2020

Positive Results Reported from Phase 3 Plaque Psoriasis Trial

By Adam Hochron

A phase 3 clinical trial for apremilast showed “significant improvements” in patients with mild-to-moderate plaque psoriasis, according to a press release from the manufacturer...

Positive Results Reported from Phase 3 Plaque Psoriasis Trial
May 11, 2020

First-Line Andecaliximab with mFOLFOX6 Fails to Improve Advanced Gastric Cancer Survival

By Michael Vlessides, /alert Contributor
An international, multi-center investigation has concluded that combining the experimental humanized monoclonal antibody andecaliximab with modified FOLFOX6 therapy does not improve overall survival...
First-Line Andecaliximab with mFOLFOX6 Fails to Improve Advanced Gastric Cancer Survival
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Rituximab with chemotherapy effective against advanced childhood Burkitt's lymphoma

By Gene Emery (Reuters Health) - Six doses of rituximab can help children with high-grade, high-risk mature B-cell non-Hodgkin's lymphoma live longer, but at a risk of infections and Read More »

Jury out on benefits, harms of ventilation strategies for COVID-19

By Marilynn Larkin NEW YORK (Reuters Health) - Evidence is lacking on the effectiveness of noninvasive ventilation (NIV) and invasive mechanical ventilation (IMV) for COVID-19 patients, and the safety Read More »

Migraines during pregnancy associated with increased maternal stroke risk

By Lisa Rappaport (Reuters Health) - Women who experience migraines during pregnancy are more likely to have a stroke during pregnancy, delivery, or the postpartum period, a new study suggests. Read More »

IntelliCare mobile apps associated with improved anxiety, depression

By Lisa Rappaport (Reuters Health) - IntelliCare, a coach-supported suite of apps designed to improve mental health, may help ease depression and anxiety symptoms in primary care patients, a small Read More »

COVID SCIENCE-Convalescent plasma not helpful in China study; timing of test may affect result

By Nancy Lapid June 3 (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the Read More »

Even with 10-day wait, suicide by gun 100 times higher within month of purchase

By Gene Emery (Reuters Health) - The risk of suicide by firearm jumps 100-fold during the first month after purchasing a handgun, even if the buyer is subject to a 10-day waiting period, according to Read More »

Malaria drug touted by Trump ineffective to prevent COVID-19 in high profile study

By Michael Erman (Reuters) - The malaria drug promoted by U.S. President Donald Trump as a treatment for COVID-19 was shown to be ineffective in preventing infection in people exposed to the Read More »

'Global epicenter' of problematic cholesterol has shifted

By Linda Carroll (Reuters Health) - High cholesterol is on the rise in low- and middle-income countries while declining in wealthier ones, an international team of researchers finds in a new analysis. Read More »

See all news »

Featured Video

Major Advances in Urology Care

Major Advances in Urology Care

Guy T. Bernstein, MD, FACS, of Urology Health Specialists discusses major advances in care over the next five years. 

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information